Navigation Links
3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia
Date:2/8/2010

marily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com

About Panacor Bioscience Ltd

Panacor Bioscience Ltd. is an emerging biopharmaceutical company focused on the development of innovative drug products that address unmet medical needs. Panacor possesses the expertise to develop its products for global registration and maximum commercial potential. Panacor has built a significant product pipeline that can enter into various stages of clinical development. Its lead product, Nephoxil, is entering Phase III clinical study and in global collaboration with multiple renowned pharmaceutical partners.

Safe Harbor Statement

This press release contains statements of a forward-looking nature. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. The accuracy of these statements may be impacted by a number of business factors and uncertainties that could cause actual results to differ materially from those projected or anticipated, including factors related to: the risks related to 3SBio's ability to successfully initiate and complete clinical trials for Nephoxil in China, including the risk that clinical trials conducted by Panacor Bioscience for Nephoxil in the U.S., Taiwan or elsewhere could produce negative results which adversely affect 3SBio's trials and registration; the risk that the Taiwan Ministry of Eco
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
4. 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
5. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
6. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
8. 3SBio Inc. Announces Change to the Board of Directors
9. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
10. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
11. 3SBio Inc. Approves Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Md. , Aug. 19, 2014 CSSi, ... research industry, recently announced the formation of the company,s ... to announce the addition of Dr. William E. ... - http://photos.prnewswire.com/prnh/20140818/136957 The MCAB, ... a variety of therapeutic areas and set strategic goals ...
(Date:8/18/2014)... 2014 2014 Deep Research Report ... professional and in-depth research report on the China ... information, including its definition, classification, application, and industry ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis. The ...
(Date:8/18/2014)... unprecedented efficiency and data storage may someday ... electric polarizations to read and write digital ... data-driven technology. But ferroelectrics must first overcome ... curious habit of "forgetting" stored data. ... of Energy,s Brookhaven National Laboratory have discovered ...
(Date:8/18/2014)... JUPITER, Fla. , Aug. 18, 2014 /PRNewswire/ ... global biotechnology company whose patented and proprietary technologies ... and other proteins for the bioenergy, bio-based chemical, ... it has filed a Registration Statement on Form ... (the "SEC"). Logo - http://photos.prnewswire.com/prnh/20110621/CL06708LOGO ...
Breaking Biology Technology:CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4Promising ferroelectric materials suffer from unexpected electric polarizations 2Promising ferroelectric materials suffer from unexpected electric polarizations 3Promising ferroelectric materials suffer from unexpected electric polarizations 4Dyadic International Files Form 10 Registration Statement 2Dyadic International Files Form 10 Registration Statement 3Dyadic International Files Form 10 Registration Statement 4
... Calif., May 6 Nektar Therapeutics (Nasdaq: NKTR ... ended March 31, 2009. Net loss for the quarter ended ... compared to net loss of $40.7 million or $0.44 per ... made improvements to its operating efficiencies as compared to a ...
... Bill Clinton will,participate as one of the main speakers at ... 3 in Sao Paulo, Brazil. The event is organized by ... most,important gatherings focused on biofuels in the world. , ... awarded a second term,in six decades. After leaving the White ...
... ChanTest, the leading expert in ion channels and GPCRs ... and safety -- is one of eight organizations slated ... Commercialization Program. Governor Ted Strickland and Interim Director of ... Ohio Third Frontier Commission, Mark Barbash, announced the competitive ...
Cached Biology Technology:Nektar Therapeutics Reports First Quarter 2009 Financial Results 2Nektar Therapeutics Reports First Quarter 2009 Financial Results 3Nektar Therapeutics Reports First Quarter 2009 Financial Results 4Nektar Therapeutics Reports First Quarter 2009 Financial Results 5Nektar Therapeutics Reports First Quarter 2009 Financial Results 6Nektar Therapeutics Reports First Quarter 2009 Financial Results 7Nektar Therapeutics Reports First Quarter 2009 Financial Results 8Nektar Therapeutics Reports First Quarter 2009 Financial Results 9President Bill Clinton to Speak at the Ethanol Summit in Brazil 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 3
(Date:8/19/2014)... A new study of 9- and 10-year-olds finds ... fibrous and compact white-matter tracts in the brain than ... the bundles of axons that carry nerve signals from ... is associated with faster and more efficient nerve activity. ... open-access journal Frontiers in Human Neuroscience. , "Previous ...
(Date:8/18/2014)... in a person,s gut may protect against or increase ... of human bacterial intestinal inflammation, according research published this ... of the American Society for Microbiology. The study also ... changes to one,s gut bacteria composition. , "It has ... or microorganisms in the gut, can protect a person ...
(Date:8/18/2014)... the Earth,s land mass is made up of rangelands, ... transformed at an alarming rate. Woody plants, such as ... leading to a loss of critical habitat and causing ... produce food specifically meat. , Researchers with ... investigation that quantified this loss in both the United ...
Breaking Biology News(10 mins):Physically fit kids have beefier brain white matter than their less-fit peers 2Physically fit kids have beefier brain white matter than their less-fit peers 3What's in your gut? Certain bacteria may influence susceptibility to infection 2Trees and shrubs invading critical grasslands, diminish cattle production 2Trees and shrubs invading critical grasslands, diminish cattle production 3
... A new study suggests that jewel scarab beetles find ... that creates the 3D effects for the blockbuster movie ... Texas, the jewel scarab species Chrysina gloriosa ... ability could provide the beetles with a tremendous advantage, ...
... Lovn Centre for Marine Sciences at the University of Gothenburg ... in the Gullmarsfjord north of Gothenburg. The bacterium has been ... marine research center. Researcher Matthias Obst from the ... at the Sven Lovn Centre for Marine Sciences, a new ...
... Boston, MA A tobacco company,s new, dissolvable ... but which in some cases resembles popular candies--could lead ... new study from the Harvard School of Public Health ... for Disease Control and Prevention (CDC) and the Food ...
Cached Biology News:Beetles stand out using 'Avatar' tech 2Tobacco company's new, dissolvable nicotine products could lead to accidental poisoning 2
... SeeDNA co-precipitant, 250 ul ... color ensures easy pellet ... acid recovery.Chemically inert, compatible ... applications.Simple 5-minute protocol. Category: ...
EDTA, 0.5 M solution, 100 ml. Ethylene diaminetetraacetic acid.Sterile, nuclease-free. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Recombinant Mouse sTNF RII/TNFRSF1B...
Mouse Wnt-11 Affinity Purified Polyclonal Ab...
Biology Products: